| 摘要: |
| 罗米地辛(又称FK228)是紫色色杆菌中非核糖体肽合酶(NRPS)和I型聚酮合酶(PKS)催化合成的一种缩酚酸肽类天然产物,具有组蛋白脱乙酰基酶抑制剂活性,现被用于皮肤T细胞淋巴瘤和外周T细胞淋巴瘤的临床治疗。我们对已发现的罗米地辛类天然产物的化学结构,生物合成基因簇和生物合成途径的研究现状进行了总结,在此基础上初步探讨了通过基因组挖掘和组合生物合成等生物学手段获取新的罗米地辛类天然产物的可能性。 |
| 关键词: 罗米地辛 组蛋白脱乙酰基酶抑制剂 生物合成基因簇 基因组挖掘 组合生物合成 |
| DOI:10.13506/j.cnki.jpr.2017.12.001 |
| 基金项目:国家自然科学基金项目(No.81373305、31401057) |
|
|
|
| Biosynthesis of romidepsin-class anticancer drugs |
| TONG Tiantian,YUN Xuan1,CHENG Yiqiang1,2,DENG Zixin1,ZHU Dongqing1 |
| (1.Key Laboratory of Combinatorial Biosynthesis and Drug Discovery,Ministry of Education, School of Pharmaceutical Sciences,WuhanUniversity,Wuhan 430071,China;2.UNT System College of Pharmacy,University of North Texas Health Science Center,Texas 76107,USA) |
| Abstract: |
| Romidepsin (also known as FK228),a depsipeptide natural product biosynthesized by nonribosomal peptide synthases (NRPSs) and type I polyketide synthases (PKSs) in Chromobacteriumviolaceum, was identified as a potent histone deacetylase inhibitor (HDACi) and approved by the US FDA for the treatments of cutaneous T-cell lymphoma and peripheral T-cell lymphoma.In this paper,the progress regarding romidepsin-classnatural products identified in chemical structures,biosynthetic gene clusters and biosynthetic pathways werereviewed.The possibility of obtaining new romidepsin analogues via genome mining and combinatorial biosynthesis were also discussed. |
| Key words: Romidepsin Histone deacetylase inhibitor Biosynthetic gene cluster Genomemining Combinatorial biosynthesis |